Glenmark Pharma’s US subsidiary has agreed to pay $15.28 million to settle antitrust litigation with Humana over allegations ...

More than 15 states have unconditional cash transfer schemes for women across India, costing roughly ₹2.68 lakh crores and ...

Former Chief Justice of India DY Chandrachud has taken on a new international legal role after being appointed by Russia as its arbitrator in an investment treaty dispute involving Ukraine's ...

Four equity mutual fund categories — large-cap, dividend yield, value, and ELSS funds — witnessed net outflows in July 2026, even as most delivered positive returns during the month. While large-cap ...

N Chandrasekaran resigned as chairman of Tata Sons today, saying he will complete his current term without seeking reappointment. His departure is linked to shareholder tensions. Read more about his ...

Two US media groups have sued President Trump over his company’s plan to charge for early access to his Truth Social posts, claiming it is unconstitutional and corrupt.

A controversy over an alleged “lungiwala” remark by Bharatiya Janata Party (BJP) MP Sushmita Dev against the Communist Party of India (Marxist) CPI(M) MP John Brittas during Monday’s proceedings ...

AI Quick Read Global financial institution Bank of America Corp (BofA) will acquire up to 49.9% in Jio Credit Ltd, the wholly-owned lending subsidiary of Jio Financial Services Ltd, for $1.9 billion, ...

Jio Financial Services Limited (JFSL) and Bank of America Corporation (BofA) have signed a definitive agreement under which BofA will acquire up to a 49.9% stake in JFSL’s wholly owned NBFC lending ...

Indian equities fell in morning trading on Wednesday, with the Nifty 50 down 0.42% and BSE Sensex down 0.44%. Investors are cautious ahead of key inflation data from India and the US, while elevated ...

Norway's $2.3 trillion sovereign wealth fund reported a record $185 billion in investment returns for the first half of the year, recovering from losses in early 2023.

The grey market is signalling strong investor interest in the Molbio Diagnostics IPO, with the latest grey market premium (GMP) standing at around ₹138 per share.